# Clarus Therapeutics Holdings Inc. (CRXT)

Source: https://www.quantisnow.com/company/CRXT
Generated: 2026-11-21T01:38:58.895Z

- Ticker: CRXT
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2021
- Website: clarustherapeutics.com

## About

Clarus Therapeutics Holdings, Inc. operates as a men's health specialty pharmaceutical company that focuses on the development and commercialization of oral testosterone replacement therapy in the United States. It offers JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company has a licensing agreement with HavaH Therapeutics for product to treat androgen-dependent inflammatory breast disease and certain forms of breast cancer. Clarus Therapeutics Holdings, Inc. was founded in 2003 and is based in Northbrook, Illinois.

## Latest CRXT news and filings

- 2023-03-01 12:35 UTC [SEC Form 15-12G filed by Clarus Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-clarus-therapeutics-holdings-inc-4140419)
- 2023-03-01 12:26 UTC [SEC Form 8-K] [Clarus Therapeutics Holdings Inc. filed SEC Form 8-K: Bankruptcy or Receivership, Completion of Acquisition or Disposition of Assets, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Other Events](https://www.quantisnow.com/insight/clarus-therapeutics-holdings-inc-filed-sec-form-8-k-bankruptcy-or-4140314)
- 2023-03-01 12:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Clarus Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-clarus-therapeutics-holdings-inc-4140287)
- 2023-03-01 12:19 UTC [SEC Form POS AM filed by Clarus Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-clarus-therapeutics-holdings-inc-4140279)
- 2023-03-01 12:16 UTC [SEC Form POS AM filed by Clarus Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-clarus-therapeutics-holdings-inc-4140265)
- 2023-03-01 12:08 UTC [SEC Form POS AM filed by Clarus Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-clarus-therapeutics-holdings-inc-4140205)
- 2023-03-01 12:06 UTC [SEC Form POS AM filed by Clarus Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-clarus-therapeutics-holdings-inc-4140196)
- 2023-02-22 21:18 UTC [SEC Form 8-K] [Clarus Therapeutics Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/clarus-therapeutics-holdings-inc-filed-sec-form-8-k-regulation-fd-4100792)
- 2023-02-14 17:29 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Clarus Therapeutics Holdings Inc. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-clarus-therapeutics-holdings-inc-4059246)
- 2023-01-24 21:01 UTC [SEC Form 8-K] [Clarus Therapeutics Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/clarus-therapeutics-holdings-inc-filed-sec-form-8-k-regulation-fd-3947992)
- 2022-12-22 21:22 UTC [SEC Form 8-K] [Clarus Therapeutics Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/clarus-therapeutics-holdings-inc-filed-sec-form-8-k-regulation-fd-3839017)
- 2022-11-23 11:09 UTC [SEC Form 8-K] [Clarus Therapeutics Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/clarus-therapeutics-holdings-inc-filed-sec-form-8-k-regulation-fd-3724148)
- 2022-10-31 20:15 UTC [SEC Form 8-K] [Clarus Therapeutics Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Leadership Update, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/clarus-therapeutics-holdings-inc-filed-sec-form-8-k-entry-into-3603630)
- 2022-10-24 20:16 UTC [SEC Form 8-K] [Clarus Therapeutics Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/clarus-therapeutics-holdings-inc-filed-sec-form-8-k-regulation-fd-3568748)
- 2022-10-18 20:10 UTC [SEC Form 8-K] [Clarus Therapeutics Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/clarus-therapeutics-holdings-inc-filed-sec-form-8-k-other-events-3546370)
- 2022-10-18 20:05 UTC [Clarus Therapeutics Holdings, Inc. Announces Completion of Auction for Sale of JATENZO® and Selection of Tolmar, Inc. as Successful Bidder](https://www.quantisnow.com/insight/clarus-therapeutics-holdings-inc-announces-completion-of-auction-for-sale-3546236)
- 2022-09-15 21:02 UTC [SEC Form 8-K] [Clarus Therapeutics Holdings Inc. filed SEC Form 8-K: Changes in Registrant’s Certifying Accountant, Financial Statements and Exhibits](https://www.quantisnow.com/insight/clarus-therapeutics-holdings-inc-filed-sec-form-8-k-changes-in-3418836)
- 2022-09-14 13:52 UTC [SEC Form 25-NSE filed by Clarus Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-clarus-therapeutics-holdings-inc-3410470)
- 2022-09-06 21:21 UTC [SEC Form 8-K] [Clarus Therapeutics Holdings Inc. filed SEC Form 8-K: Bankruptcy or Receivership, Leadership Update, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/clarus-therapeutics-holdings-inc-filed-sec-form-8-k-bankruptcy-or-3379063)
- 2022-09-06 02:19 UTC [Clarus Therapeutics Holdings, Inc. Announces Plan for Near-Term Sale of JATENZO® Using Structured Process Through Chapter 11 of the U.S. Bankruptcy Code](https://www.quantisnow.com/insight/clarus-therapeutics-holdings-inc-announces-plan-for-near-term-sale-of-3373730)
- 2022-08-31 09:50 UTC [Market Insight] [Why Nikola Dropped Over 9%; Here Are 66 Biggest Movers From Yesterday](https://www.quantisnow.com/insight/why-nikola-dropped-over-9-here-are-66-biggest-movers-3356165)
- 2022-08-30 17:23 UTC [Market Insight] [Why IN8bio Is Trading Higher By 46%, Here Are 54 Stocks Moving In Tuesday's Mid-Day Session](https://www.quantisnow.com/insight/why-in8bio-is-trading-higher-by-46-here-are-54-3353599)
- 2022-08-30 16:34 UTC [Market Insight] [Stocks That Hit 52-Week Lows On Tuesday](https://www.quantisnow.com/insight/stocks-that-hit-52-week-lows-on-tuesday-3353298)
- 2022-08-30 10:54 UTC [Market Insight] [Why Baudax Bio Is Trading Lower By 34%; Here Are 26 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-baudax-bio-is-trading-lower-by-34-here-are-3350662)
- 2022-08-29 20:05 UTC [Market Insight] [Here's Why Clarus Therapeutics Shares Got Obliterated](https://www.quantisnow.com/insight/heres-why-clarus-therapeutics-shares-got-obliterated-3348700)
- 2022-08-29 16:49 UTC [Market Insight] [Why Chimerix Is Trading Higher By Over 19%, Here Are 53 Stocks Moving In Monday's Mid-Day Session](https://www.quantisnow.com/insight/why-chimerix-is-trading-higher-by-over-19-here-are-3347239)
- 2022-08-29 15:50 UTC [Market Insight] [Stocks That Hit 52-Week Lows On Monday](https://www.quantisnow.com/insight/stocks-that-hit-52-week-lows-on-monday-3346745)
- 2022-08-29 15:07 UTC [Market Chatter] [Clarus Therapeutics shares are trading lower after the company announced it has received a non-compliance letter from Nasdaq. The shares will be suspended on August 31st and will begin trading on the OTC Pink Market.](https://www.quantisnow.com/insight/clarus-therapeutics-shares-are-trading-lower-after-the-company-announced-3346454)
- 2022-08-29 14:56 UTC [Market Insight] [Clarus Therapeutics Shares Down 30% Monday After Co on Friday Announced it Received Non-Compliance Letter from Nasdaq. Shares to be Suspended on August 31 and Begin Trading on OTC Pink Market](https://www.quantisnow.com/insight/clarus-therapeutics-shares-down-30-monday-after-co-on-friday-3346328)
- 2022-08-29 09:35 UTC [Market Insight] [Why Hill International Is Trading Higher By 15%; Here Are 30 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-hill-international-is-trading-higher-by-15-here-are-3343797)
- 2022-08-26 20:35 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Clarus Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-clarus-therapeutics-holdings-inc-3342492)
- 2022-08-26 20:32 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Clarus Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-clarus-therapeutics-holdings-inc-3342434)
- 2022-08-26 20:29 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Clarus Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-clarus-therapeutics-holdings-inc-3342374)
- 2022-08-26 20:27 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Clarus Therapeutics Holdings Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-clarus-therapeutics-holdings-inc-3342336)
- 2022-08-26 20:18 UTC [SEC Form 8-K] [Clarus Therapeutics Holdings Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing](https://www.quantisnow.com/insight/clarus-therapeutics-holdings-inc-filed-sec-form-8-k-notice-of-3342229)
- 2022-08-23 14:04 UTC [Market Insight] [Benzinga's Top Ratings Upgrades, Downgrades For August 23, 2022](https://www.quantisnow.com/insight/benzingas-top-ratings-upgrades-downgrades-for-august-23-2022-3321098)
- 2022-08-23 09:18 UTC [Market Insight] [U.S. Stock Futures Edge Higher Following Monday's Sell-Off, Crude Oil Rises](https://www.quantisnow.com/insight/us-stock-futures-edge-higher-following-mondays-sell-off-crude-oil-3318930)
- 2022-08-23 09:01 UTC [Market Chatter] [Needham Downgrades Clarus Therapeutics Hldgs to Hold](https://www.quantisnow.com/insight/needham-downgrades-clarus-therapeutics-hldgs-to-hold-3318909)
- 2022-08-22 18:29 UTC [Market Insight] [Stocks That Hit 52-Week Lows On Monday](https://www.quantisnow.com/insight/stocks-that-hit-52-week-lows-on-monday-3317020)
- 2022-08-22 14:31 UTC [Market Insight] [Clarus Therapeutics shares are trading lower after Maxim Group downgraded the stock to Hold. The company last week implemented a staff reduction and terminated certain research and development activities.](https://www.quantisnow.com/insight/clarus-therapeutics-shares-are-trading-lower-after-maxim-group-downgraded-3315881)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/CRXT
- Earnings history: https://www.quantisnow.com/earnings/CRXT
- Dividend history: https://www.quantisnow.com/dividends/CRXT
- Insider transactions: https://www.quantisnow.com/insiders/CRXT
- Options chain: https://www.quantisnow.com/options/CRXT
- SEC 8-K filings only: https://www.quantisnow.com/company/CRXT/8-k
- RSS and alerts for CRXT: https://www.quantisnow.com/docs/rss-feeds.md
